Literature DB >> 1812394

Thiamine deficiency and Wernicke's encephalopathy in AIDS.

R F Butterworth1, C Gaudreau, J Vincelette, A M Bourgault, F Lamothe, A M Nutini.   

Abstract

Several neuropathological reports in the last 5 years have described brain lesions characteristic of Wernicke's Encephalopathy in patients with AIDS. Using the erythrocyte transketolase activation assay, we now report biochemical evidence of thiamine deficiency in 9/39 (23%) of patients with AIDS or AIDS-related complex. In no cases was there history of alcohol abuse nor were there clinical signs of Wernicke's Encephalopathy. Thiamine deficiency in these patients most likely results from the cachexia and catabolic state characteristic of AIDS. In view of (i) the confirmed neuropathological evidence of Wernicke's Encephalopathy in AIDS patients, (ii) the significant thiamine deficiency in these patients and (iii) the difficulties of clinical diagnosis of Wernicke's Encephalopathy, it is recommended that dietary thiamine supplementation be initiated in all newly diagnosed cases of AIDS or AIDS-related complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812394     DOI: 10.1007/BF00996920

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  18 in total

1.  Thiamine deficiency in AIDS.

Authors:  R F Butterworth; C Gaudreau; J Vincelette; A M Bourgault; F Lamothe; A M Nutini
Journal:  Lancet       Date:  1991-10-26       Impact factor: 79.321

2.  Wernicke's encephalopathy in acquired immune deficiency syndrome (AIDS): a case report.

Authors:  D Soffer; H Zirkin; M Alkan; V M Berginer
Journal:  Clin Neuropathol       Date:  1989 Jul-Aug       Impact factor: 1.368

3.  [Acquired immunodeficiency syndrome associated with disseminated tuberculosis and chronic Wernickeś encephalopathy].

Authors:  V Foresti; E Parisio; N Scolari; F Sparacio; F Confalonieri
Journal:  Recenti Prog Med       Date:  1986 Jul-Aug

4.  Wernicke's encephalopathy in AIDS patient treated with zidovudine.

Authors:  D G Davtyan; H V Vinters
Journal:  Lancet       Date:  1987-04-18       Impact factor: 79.321

5.  Wernicke's encephalopathy induced by tolazamide.

Authors:  I L Kwee; T Nakada
Journal:  N Engl J Med       Date:  1983-09-08       Impact factor: 91.245

Review 6.  Effects of thiamine deficiency on brain metabolism: implications for the pathogenesis of the Wernicke-Korsakoff syndrome.

Authors:  R F Butterworth
Journal:  Alcohol Alcohol       Date:  1989       Impact factor: 2.826

7.  Wernicke's encephalopathy in two patients with acquired immunodeficiency syndrome.

Authors:  J Schwenk; G Gosztonyi; P Thierauf; J Iglesias; E Langer
Journal:  J Neurol       Date:  1990-11       Impact factor: 4.849

8.  Transketolase abnormality in tolazamide-induced Wernicke's encephalopathy.

Authors:  A B Mukherjee; A Ghazanfari; S Svoronos; R C Staton; T Nakada; I L Kwee
Journal:  Neurology       Date:  1986-11       Impact factor: 9.910

9.  Wernicke's encephalopathy in non-alcoholics. An autopsy study.

Authors:  C F Lindboe; E M Løberg
Journal:  J Neurol Sci       Date:  1989-04       Impact factor: 3.181

10.  Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy. 2. alpha-Ketoglutarate dehydrogenase.

Authors:  R F Butterworth; J F Giguère; A M Besnard
Journal:  Neurochem Res       Date:  1986-04       Impact factor: 3.996

View more
  28 in total

1.  Beyond alcoholism: Wernicke-Korsakoff syndrome in patients with psychiatric disorders.

Authors:  Laurie M McCormick; Judith R Buchanan; Obiora E Onwuameze; Ronald K Pierson; Sergio Paradiso
Journal:  Cogn Behav Neurol       Date:  2011-12       Impact factor: 1.600

Review 2.  Neuronal cell death in hepatic encephalopathy.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 3.  Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2015-02-19

4.  An international perspective on the prevalence of the Wernicke-Korsakoff syndrome.

Authors:  C Harper; P Fornes; C Duyckaerts; D Lecomte; J J Hauw
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 5.  Neuropathology of thiamine deficiency: an update on the comparative analysis of human disorders and experimental models.

Authors:  P J Langlais; S X Zhang; L M Savage
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

Review 6.  Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 7.  Pathogenesis of diencephalic lesions in an experimental model of Wernicke's encephalopathy.

Authors:  P J Langlais
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 8.  A review on research progress of transketolase.

Authors:  Jing Zhao; Chun-Jiu Zhong
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203

Review 9.  Neuronal cell death in Wernicke's encephalopathy: pathophysiologic mechanisms and implications for PET imaging.

Authors:  D K Leong; R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

Review 10.  Neuropathology of thiamine deficiency disorders.

Authors:  J J Kril
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.